Royal Bank of Canada’s Dimension Therapeutics, Inc DMTX Stock Holding History

Royal Bank of Canada’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-9	Closed	–	–	7425
2017 Q3	$0	Buy	+9	New	+$23	﹤0.01%	7393
2017 Q2	–	Sell	-685	Closed	-$1K	–	7147
2017 Q1	$1K	Sell	685 -19	-3%	-$50	﹤0.01%	6560
2016 Q4	$3K	Buy	+704	New	+$3.75K	﹤0.01%	6452

Royal Bank of Canada's DMTX Position: Q4 2017 in Review

Royal Bank of Canada sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 9 shares.

Royal Bank of Canada first reported a position in DMTX in Q4 2016 and held it in 3 quarters. The position peaked at $3K in Q4 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Royal Bank of Canada reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Royal Bank of Canada sold 9 Dimension Therapeutics, Inc shares in Q4 2017.
Royal Bank of Canada first reported a position in Dimension Therapeutics, Inc in Q4 2016 and held it in 3 quarters.
Royal Bank of Canada's Dimension Therapeutics, Inc position peaked at $3K in Q4 2016.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.